Industry Research Reports

Home > Reports > Service & Software > Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-11

Pages: 94 Pages

Report ld: 6193949

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Genetic Disease Testing Market Size(US$)

CAGR 2026-2032

11.5%

Market Size,2032

USD 2,267

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,178 million

Market Forecast in 2032(Value)

US$ 2,267 million

CAGR

11.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Genetic Disease Testing market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 2267 million by 2032 with a CAGR of 11.5% during the forecast period 2026-2032.

Genetic disease testing, also known as genetic testing, involves analyzing chromosomes, genes, or proteins to identify changes that may lead to genetic disorders. This testing can confirm or rule out suspected genetic conditions or assess the risk of developing or passing on genetic disorders.

Market Development Overview:

In recent years, the genetic disease testing market has seen substantial growth due to advances in genomics, increased awareness of genetic diseases, and growing demand for personalized medicine. The global genetic disease testing market was valued at billions of dollars in 2023 and is expected to expand at a significant compound annual growth rate (CAGR) in the coming years. Factors driving this growth include technological advances in next-generation sequencing (NGS), declining costs of genetic testing, and expanding applications in oncology, rare disease diagnosis, and reproductive health. Governments and healthcare organizations around the world are actively promoting genetic screening programs, further driving market expansion. Direct-to-consumer (DTC) genetic testing is also becoming increasingly popular, with companies offering home testing kits for health risk assessment and ancestry tracing. The market is expected to maintain steady growth as regulators create clearer guidelines for genetic testing services.

Market Development Opportunities:

Next-generation sequencing (NGS) and CRISPR gene editing technologies are revolutionizing genetic testing, enabling faster, more accurate, and more cost-effective diagnoses. The reduction in the cost of whole genome sequencing makes genetic testing more accessible to a wider range of people. As healthcare shifts toward personalized treatment plans, genetic testing is becoming an important tool to tailor treatments to patients’ genetic profiles. Precision oncology in particular benefits from genetic insights that enable targeted cancer treatments. Many rare genetic diseases remain undiagnosed due to the complexity of traditional diagnostic methods. Advances in genetic testing are improving early detection and management of these diseases, creating new market opportunities. With consumers’ growing interest in health and ancestry, demand for direct-to-consumer genetic testing companies has surged. Companies are also developing AI-driven analytics to provide more personalized insights from genetic data.

Market Risks and Challenges:

Genetic testing raises ethical questions about data privacy, consent, and potential misuse of genetic information. Governments are implementing stricter regulations, which could impact market growth if compliance costs increase. As genetic testing companies collect large amounts of sensitive personal data, the risk of data breaches and misuse continues to increase. Ensuring secure storage and ethical use of genetic data is a key concern for industry stakeholders. Despite declining sequencing costs, genetic testing remains expensive in many regions, limiting accessibility to low-income populations. Insurance coverage for genetic testing also varies, impacting adoption rates. Without appropriate genetic counseling, consumers and patients may misinterpret test results, leading to unnecessary anxiety or inappropriate medical decisions. Expanding access to genetic counseling services is critical to mitigating this risk.

The global Genetic Disease Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Invitae
Ambry Genetics
Exact Sciences
Qiagen
Tempus
23andme
Veritas Genetics
Myriad Genetics
LabCorp
Blueprint Genetics
Illumina
CENTOGENE
GeneDx
Fulgent Genetics
BGI Genomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Direct Genetic Testing
Indirect Genetic Testing

Segment by Application

Carrier Testing
Prenatal Testing
Newborn Screening
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Genetic Disease Testing value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Direct Genetic Testing

1.2.3 Indirect Genetic Testing

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Carrier Testing

1.3.3 Prenatal Testing

1.3.4 Newborn Screening

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Disease Testing Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Genetic Disease Testing Market Share by Revenue, by Region (2021-2026)

2.4 Global Genetic Disease Testing Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Genetic Disease Testing Market Size and Prospective (2021-2032)

2.5.2 Europe Genetic Disease Testing Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Genetic Disease Testing Market Size and Prospective (2021-2032)

2.5.4 Latin America Genetic Disease Testing Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Genetic Disease Testing Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Genetic Disease Testing Historical Market Size by Type (2021-2026)

3.2 Global Genetic Disease Testing Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Genetic Disease Testing

4 Breakdown Data by Application

4.1 Global Genetic Disease Testing Historical Market Size by Application (2021-2026)

4.2 Global Genetic Disease Testing Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Genetic Disease Testing Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Genetic Disease Testing Players by Revenue (2021-2026)

5.1.2 Global Genetic Disease Testing Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Genetic Disease Testing Revenue

5.4 Global Genetic Disease Testing Market Concentration Analysis

5.4.1 Global Genetic Disease Testing Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Testing Revenue in 2025

5.5 Global Key Players of Genetic Disease Testing Head Offices and Areas Served

5.6 Global Key Players of Genetic Disease Testing, Product and Application

5.7 Global Key Players of Genetic Disease Testing, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Genetic Disease Testing Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Genetic Disease Testing Market Size by Type (2021-2026)

6.1.2.2 North America Genetic Disease Testing Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Genetic Disease Testing Market Size by Application (2021-2026)

6.1.3.2 North America Genetic Disease Testing Market Share by Application (2021-2026)

6.1.4 North America Genetic Disease Testing Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Genetic Disease Testing Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Genetic Disease Testing Market Size by Type (2021-2026)

6.2.2.2 Europe Genetic Disease Testing Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Genetic Disease Testing Market Size by Application (2021-2026)

6.2.3.2 Europe Genetic Disease Testing Market Share by Application (2021-2026)

6.2.4 Europe Genetic Disease Testing Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Genetic Disease Testing Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Genetic Disease Testing Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Genetic Disease Testing Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Genetic Disease Testing Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Genetic Disease Testing Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Genetic Disease Testing Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Genetic Disease Testing Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Genetic Disease Testing Market Size by Type (2021-2026)

6.4.2.2 Latin America Genetic Disease Testing Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Genetic Disease Testing Market Size by Application (2021-2026)

6.4.3.2 Latin America Genetic Disease Testing Market Share by Application (2021-2026)

6.4.4 Latin America Genetic Disease Testing Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Genetic Disease Testing Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Genetic Disease Testing Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Genetic Disease Testing Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Genetic Disease Testing Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Genetic Disease Testing Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Genetic Disease Testing Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles

7.1 Invitae

7.1.1 Invitae Company Details

7.1.2 Invitae Business Overview

7.1.3 Invitae Genetic Disease Testing Introduction

7.1.4 Invitae Revenue in Genetic Disease Testing Business (2021-2026)

7.1.5 Invitae Recent Development

7.2 Ambry Genetics

7.2.1 Ambry Genetics Company Details

7.2.2 Ambry Genetics Business Overview

7.2.3 Ambry Genetics Genetic Disease Testing Introduction

7.2.4 Ambry Genetics Revenue in Genetic Disease Testing Business (2021-2026)

7.2.5 Ambry Genetics Recent Development

7.3 Exact Sciences

7.3.1 Exact Sciences Company Details

7.3.2 Exact Sciences Business Overview

7.3.3 Exact Sciences Genetic Disease Testing Introduction

7.3.4 Exact Sciences Revenue in Genetic Disease Testing Business (2021-2026)

7.3.5 Exact Sciences Recent Development

7.4 Qiagen

7.4.1 Qiagen Company Details

7.4.2 Qiagen Business Overview

7.4.3 Qiagen Genetic Disease Testing Introduction

7.4.4 Qiagen Revenue in Genetic Disease Testing Business (2021-2026)

7.4.5 Qiagen Recent Development

7.5 Tempus

7.5.1 Tempus Company Details

7.5.2 Tempus Business Overview

7.5.3 Tempus Genetic Disease Testing Introduction

7.5.4 Tempus Revenue in Genetic Disease Testing Business (2021-2026)

7.5.5 Tempus Recent Development

7.6 23andme

7.6.1 23andme Company Details

7.6.2 23andme Business Overview

7.6.3 23andme Genetic Disease Testing Introduction

7.6.4 23andme Revenue in Genetic Disease Testing Business (2021-2026)

7.6.5 23andme Recent Development

7.7 Veritas Genetics

7.7.1 Veritas Genetics Company Details

7.7.2 Veritas Genetics Business Overview

7.7.3 Veritas Genetics Genetic Disease Testing Introduction

7.7.4 Veritas Genetics Revenue in Genetic Disease Testing Business (2021-2026)

7.7.5 Veritas Genetics Recent Development

7.8 Myriad Genetics

7.8.1 Myriad Genetics Company Details

7.8.2 Myriad Genetics Business Overview

7.8.3 Myriad Genetics Genetic Disease Testing Introduction

7.8.4 Myriad Genetics Revenue in Genetic Disease Testing Business (2021-2026)

7.8.5 Myriad Genetics Recent Development

7.9 LabCorp

7.9.1 LabCorp Company Details

7.9.2 LabCorp Business Overview

7.9.3 LabCorp Genetic Disease Testing Introduction

7.9.4 LabCorp Revenue in Genetic Disease Testing Business (2021-2026)

7.9.5 LabCorp Recent Development

7.10 Blueprint Genetics

7.10.1 Blueprint Genetics Company Details

7.10.2 Blueprint Genetics Business Overview

7.10.3 Blueprint Genetics Genetic Disease Testing Introduction

7.10.4 Blueprint Genetics Revenue in Genetic Disease Testing Business (2021-2026)

7.10.5 Blueprint Genetics Recent Development

7.11 Illumina

7.11.1 Illumina Company Details

7.11.2 Illumina Business Overview

7.11.3 Illumina Genetic Disease Testing Introduction

7.11.4 Illumina Revenue in Genetic Disease Testing Business (2021-2026)

7.11.5 Illumina Recent Development

7.12 CENTOGENE

7.12.1 CENTOGENE Company Details

7.12.2 CENTOGENE Business Overview

7.12.3 CENTOGENE Genetic Disease Testing Introduction

7.12.4 CENTOGENE Revenue in Genetic Disease Testing Business (2021-2026)

7.12.5 CENTOGENE Recent Development

7.13 GeneDx

7.13.1 GeneDx Company Details

7.13.2 GeneDx Business Overview

7.13.3 GeneDx Genetic Disease Testing Introduction

7.13.4 GeneDx Revenue in Genetic Disease Testing Business (2021-2026)

7.13.5 GeneDx Recent Development

7.14 Fulgent Genetics

7.14.1 Fulgent Genetics Company Details

7.14.2 Fulgent Genetics Business Overview

7.14.3 Fulgent Genetics Genetic Disease Testing Introduction

7.14.4 Fulgent Genetics Revenue in Genetic Disease Testing Business (2021-2026)

7.14.5 Fulgent Genetics Recent Development

7.15 BGI Genomics

7.15.1 BGI Genomics Company Details

7.15.2 BGI Genomics Business Overview

7.15.3 BGI Genomics Genetic Disease Testing Introduction

7.15.4 BGI Genomics Revenue in Genetic Disease Testing Business (2021-2026)

7.15.5 BGI Genomics Recent Development

8 Genetic Disease Testing Market Dynamics

8.1 Genetic Disease Testing Industry Trends

8.2 Genetic Disease Testing Market Drivers

8.3 Genetic Disease Testing Market Challenges

8.4 Genetic Disease Testing Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Genetic Disease Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Genetic Disease Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Genetic Disease Testing Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Genetic Disease Testing Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Genetic Disease Testing Revenue Share by Region (2021-2026)

Table 6. Global Genetic Disease Testing Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Genetic Disease Testing Revenue Share Forecast by Region (2027-2032)

Table 8. Global Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Genetic Disease Testing Market Share by Revenue, by Type (2021-2026)

Table 10. Global Genetic Disease Testing Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Genetic Disease Testing Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Genetic Disease Testing Market Share by Revenue, by Application (2021-2026)

Table 15. Global Genetic Disease Testing Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Genetic Disease Testing Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Genetic Disease Testing Applications

Table 18. Global Genetic Disease Testing Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Genetic Disease Testing Market Share by Players (2021-2026)

Table 20. Global Top Genetic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Testing as of 2025)

Table 21. Ranking of Global Top Genetic Disease Testing Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Genetic Disease Testing Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Genetic Disease Testing, Headquarters and Area Served

Table 24. Global Key Players of Genetic Disease Testing, Product and Application

Table 25. Global Key Players of Genetic Disease Testing, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Genetic Disease Testing Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Genetic Disease Testing Market Share by Revenue, by Company (2021-2026)

Table 29. North America Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Genetic Disease Testing Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Genetic Disease Testing Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 35. Asia-Pacific Genetic Disease Testing Revenue by Company (2021-2026) & (US$ Million)

Table 36. Asia-Pacific Genetic Disease Testing Market Share by Revenue, by Company (2021-2026)

Table 37. Asia-Pacific Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 38. Asia-Pacific Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 39. Latin America Genetic Disease Testing Revenue by Company (2021-2026) & (US$ Million)

Table 40. Latin America Genetic Disease Testing Market Share by Revenue, by Company (2021-2026)

Table 41. Latin America Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 42. Latin America Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 43. Middle East & Africa Genetic Disease Testing Revenue by Company (2021-2026) & (US$ Million)

Table 44. Middle East & Africa Genetic Disease Testing Market Share by Revenue, by Company (2021-2026)

Table 45. Middle East & Africa Genetic Disease Testing Market Size by Type (2021-2026) & (US$ Million)

Table 46. Middle East & Africa Genetic Disease Testing Market Size by Application (2021-2026) & (US$ Million)

Table 47. Invitae Company Details

Table 48. Invitae Business Overview

Table 49. Invitae Genetic Disease Testing Product

Table 50. Invitae Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 51. Invitae Recent Development

Table 52. Ambry Genetics Company Details

Table 53. Ambry Genetics Business Overview

Table 54. Ambry Genetics Genetic Disease Testing Product

Table 55. Ambry Genetics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 56. Ambry Genetics Recent Development

Table 57. Exact Sciences Company Details

Table 58. Exact Sciences Business Overview

Table 59. Exact Sciences Genetic Disease Testing Product

Table 60. Exact Sciences Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 61. Exact Sciences Recent Development

Table 62. Qiagen Company Details

Table 63. Qiagen Business Overview

Table 64. Qiagen Genetic Disease Testing Product

Table 65. Qiagen Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 66. Qiagen Recent Development

Table 67. Tempus Company Details

Table 68. Tempus Business Overview

Table 69. Tempus Genetic Disease Testing Product

Table 70. Tempus Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 71. Tempus Recent Development

Table 72. 23andme Company Details

Table 73. 23andme Business Overview

Table 74. 23andme Genetic Disease Testing Product

Table 75. 23andme Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 76. 23andme Recent Development

Table 77. Veritas Genetics Company Details

Table 78. Veritas Genetics Business Overview

Table 79. Veritas Genetics Genetic Disease Testing Product

Table 80. Veritas Genetics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 81. Veritas Genetics Recent Development

Table 82. Myriad Genetics Company Details

Table 83. Myriad Genetics Business Overview

Table 84. Myriad Genetics Genetic Disease Testing Product

Table 85. Myriad Genetics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 86. Myriad Genetics Recent Development

Table 87. LabCorp Company Details

Table 88. LabCorp Business Overview

Table 89. LabCorp Genetic Disease Testing Product

Table 90. LabCorp Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 91. LabCorp Recent Development

Table 92. Blueprint Genetics Company Details

Table 93. Blueprint Genetics Business Overview

Table 94. Blueprint Genetics Genetic Disease Testing Product

Table 95. Blueprint Genetics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 96. Blueprint Genetics Recent Development

Table 97. Illumina Company Details

Table 98. Illumina Business Overview

Table 99. Illumina Genetic Disease Testing Product

Table 100. Illumina Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 101. Illumina Recent Development

Table 102. CENTOGENE Company Details

Table 103. CENTOGENE Business Overview

Table 104. CENTOGENE Genetic Disease Testing Product

Table 105. CENTOGENE Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 106. CENTOGENE Recent Development

Table 107. GeneDx Company Details

Table 108. GeneDx Business Overview

Table 109. GeneDx Genetic Disease Testing Product

Table 110. GeneDx Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 111. GeneDx Recent Development

Table 112. Fulgent Genetics Company Details

Table 113. Fulgent Genetics Business Overview

Table 114. Fulgent Genetics Genetic Disease Testing Product

Table 115. Fulgent Genetics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 116. Fulgent Genetics Recent Development

Table 117. BGI Genomics Company Details

Table 118. BGI Genomics Business Overview

Table 119. BGI Genomics Genetic Disease Testing Product

Table 120. BGI Genomics Revenue in Genetic Disease Testing Business (2021-2026) & (US$ Million)

Table 121. BGI Genomics Recent Development

Table 122. Genetic Disease Testing Market Trends

Table 123. Genetic Disease Testing Market Drivers

Table 124. Genetic Disease Testing Market Challenges

Table 125. Genetic Disease Testing Market Restraints

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Genetic Disease Testing Product Picture

Figure 2. Global Genetic Disease Testing Market Share by Type: 2025 vs 2032

Figure 3. Direct Genetic Testing Features

Figure 4. Indirect Genetic Testing Features

Figure 5. Global Genetic Disease Testing Market Share by Application: 2025 vs 2032

Figure 6. Carrier Testing

Figure 7. Prenatal Testing

Figure 8. Newborn Screening

Figure 9. Others

Figure 10. Genetic Disease Testing Report Years Considered

Figure 11. Global Genetic Disease Testing Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 12. Global Genetic Disease Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Genetic Disease Testing Market Share by Revenue, by Region: 2021 vs 2025

Figure 14. North America Genetic Disease Testing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. Europe Genetic Disease Testing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. Asia-Pacific Genetic Disease Testing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Latin America Genetic Disease Testing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. Middle East & Africa Genetic Disease Testing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. Global Genetic Disease Testing Market Share by Players in 2025

Figure 20. Global Top Genetic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Testing as of 2025)

Figure 21. The Top 10 and 5 Players Market Share by Genetic Disease Testing Revenue in 2025

Figure 22. North America Genetic Disease Testing Market Share by Type (2021-2026)

Figure 23. North America Genetic Disease Testing Market Share by Application (2021-2026)

Figure 24. Europe Genetic Disease Testing Market Share by Type (2021-2026)

Figure 25. Europe Genetic Disease Testing Market Share by Application (2021-2026)

Figure 26. Asia-Pacific Genetic Disease Testing Market Share by Type (2021-2026)

Figure 27. Asia-Pacific Genetic Disease Testing Market Share by Application (2021-2026)

Figure 28. Latin America Genetic Disease Testing Market Share by Type (2021-2026)

Figure 29. Latin America Genetic Disease Testing Market Share by Application (2021-2026)

Figure 30. Middle East & Africa Genetic Disease Testing Market Share by Type (2021-2026)

Figure 31. Middle East & Africa Genetic Disease Testing Market Share by Application (2021-2026)

Figure 32. Invitae Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 33. Ambry Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 34. Exact Sciences Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 35. Qiagen Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 36. Tempus Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 37. 23andme Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 38. Veritas Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 39. Myriad Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 40. LabCorp Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 41. Blueprint Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 42. Illumina Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 43. CENTOGENE Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 44. GeneDx Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 45. Fulgent Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 46. BGI Genomics Revenue Growth Rate in Genetic Disease Testing Business (2021-2026)

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Genetic Disease Testing in 2032? zhanKai

The global market size of Genetic Disease Testing in 2032 was 2267 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Genetic Disease Testing market? shouQi

What was the global market size of Genetic Disease Testing in 2026? shouQi

What is the annual compound growth rate of the global Genetic Disease Testing market size from 2026 to 2032? shouQi

Related Reports

Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 145
USD 4900.00
(Single User License)
Global Genetic Disease Testing Market Research Report 2026
The global Genetic Disease Testing market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 2267 million by 2032, at a CAGR of 11.5% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 111
USD 2900.00
(Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Genetic Disease Testing was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 2267 million, growing at a CAGR of 11.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 106
USD 3950.00
(Single User License)
Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 132
USD 4900.00
(Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 95
USD 4250.00
(Single User License)
Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 87
USD 2900.00
(Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 101
USD 3950.00
(Single User License)

Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 145
USD 4900.00 (Single User License)
Global Genetic Disease Testing Market Research Report 2026
The global Genetic Disease Testing market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 2267 million by 2032, at a CAGR of 11.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 111
USD 2900.00 (Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Genetic Disease Testing was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 2267 million, growing at a CAGR of 11.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 106
USD 3950.00 (Single User License)
Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 132
USD 4900.00 (Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 95
USD 4250.00 (Single User License)
Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 87
USD 2900.00 (Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 101
USD 3950.00 (Single User License)